Boston Scientific Corporation (NYSE:BSX) CEO Mike Mahoney set the theme at the company’s 2023 Investor Day event as “next level,’ stating that his goal was to make Boston Scientific a “compelling” and “fantastic place to be 10 years from now.”
Mizuho Securities maintained its Neutral rating and raised the price target from $56 to $60.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased